Immunogenicity of a third dose of inactivated COVID-19 vaccine in people living with HIV-1, HBV, and tuberculosis during the Omicron variant epidemic: A cross-sectional study

Detalles Bibliográficos
Autores principales: Yan, Yan, Davgadorj, Chantsalmaa, Lyu, Chunyan, Zhang, Shiliang, Qiu, Yuanwang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254457/
https://www.ncbi.nlm.nih.gov/pubmed/35803384
http://dx.doi.org/10.1016/j.jinf.2022.06.032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254457/
https://www.ncbi.nlm.nih.gov/pubmed/35803384
http://dx.doi.org/10.1016/j.jinf.2022.06.032

Ejemplares similares